Literature DB >> 31611357

A Dutch Case Report of Successful Treatment of Chronic Relapsing Urinary Tract Infection with Bacteriophages in a Renal Transplant Patient.

Saskia Kuipers1, Mike M Ruth2, Mike Mientjes2, Ruud G L de Sévaux3, Jakko van Ingen2.   

Abstract

We report a case of a 58-year-old renal transplant patient who developed a recurrent urinary tract infection with an extended-spectrum β-lactamase (ESBL)-positive Klebsiella pneumoniae strain in the first month posttransplant. Even though it tested susceptible to carbapenems and despite repeated meropenem treatment, his infection recurred. The infection eventually evolved into epididymitis that was successfully treated with meropenem and bacteriophages. This case demonstrates the difficulty of treating relapsing ESBL-positive Gram-negative infections in renal transplant patients.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Klebsiella pneumoniaezzm321990; bacteriophages; extended spectrum β-lactamase; renal transplant; urinary tract infection

Year:  2019        PMID: 31611357      PMCID: PMC7187595          DOI: 10.1128/AAC.01281-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

Review 1.  Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria.

Authors:  Kaitlyn E Kortright; Benjamin K Chan; Jonathan L Koff; Paul E Turner
Journal:  Cell Host Microbe       Date:  2019-02-13       Impact factor: 21.023

Review 2.  Urinary tract infections caused by ESBL-producing Enterobacteriaceae in renal transplant recipients: A systematic review and meta-analysis.

Authors:  Michail Alevizakos; Dimitrios Nasioudis; Eleftherios Mylonakis
Journal:  Transpl Infect Dis       Date:  2017-10-24       Impact factor: 2.228

3.  Development and Use of Personalized Bacteriophage-Based Therapeutic Cocktails To Treat a Patient with a Disseminated Resistant Acinetobacter baumannii Infection.

Authors:  Robert T Schooley; Biswajit Biswas; Jason J Gill; Adriana Hernandez-Morales; Jacob Lancaster; Lauren Lessor; Jeremy J Barr; Sharon L Reed; Forest Rohwer; Sean Benler; Anca M Segall; Randy Taplitz; Davey M Smith; Kim Kerr; Monika Kumaraswamy; Victor Nizet; Leo Lin; Melanie D McCauley; Steffanie A Strathdee; Constance A Benson; Robert K Pope; Brian M Leroux; Andrew C Picel; Alfred J Mateczun; Katherine E Cilwa; James M Regeimbal; Luis A Estrella; David M Wolfe; Matthew S Henry; Javier Quinones; Scott Salka; Kimberly A Bishop-Lilly; Ry Young; Theron Hamilton
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

Review 4.  Managing chronic bladder diseases with the administration of exogenous glycosaminoglycans: an update on the evidence.

Authors:  Massimo Lazzeri; Rodolfo Hurle; Paolo Casale; NicolòMaria Buffi; Giovanni Lughezzani; Girolamo Fiorini; Roberto Peschechera; Luisa Pasini; Silvia Zandegiacomo; Alessio Benetti; Gianluigi Taverna; Giorgio Guazzoni; Guido Barbagli
Journal:  Ther Adv Urol       Date:  2015-12-16

5.  Bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomized, placebo-controlled, double-blind clinical trial.

Authors:  Lorenz Leitner; Wilbert Sybesma; Nina Chanishvili; Marina Goderdzishvili; Archil Chkhotua; Aleksandre Ujmajuridze; Marc P Schneider; Andrea Sartori; Ulrich Mehnert; Lucas M Bachmann; Thomas M Kessler
Journal:  BMC Urol       Date:  2017-09-26       Impact factor: 2.264

6.  Adapted Bacteriophages for Treating Urinary Tract Infections.

Authors:  Aleksandre Ujmajuridze; Nina Chanishvili; Marina Goderdzishvili; Lorenz Leitner; Ulrich Mehnert; Archil Chkhotua; Thomas M Kessler; Wilbert Sybesma
Journal:  Front Microbiol       Date:  2018-08-07       Impact factor: 5.640

7.  Bacteriophages as Potential Treatment for Urinary Tract Infections.

Authors:  Wilbert Sybesma; Reinhard Zbinden; Nino Chanishvili; Mzia Kutateladze; Archil Chkhotua; Aleksandre Ujmajuridze; Ulrich Mehnert; Thomas M Kessler
Journal:  Front Microbiol       Date:  2016-04-11       Impact factor: 5.640

  7 in total
  14 in total

1.  What's Old Is New Again: Bacteriophage Therapy in the 21st Century.

Authors:  Saima Aslam; Robert T Schooley
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

Review 2.  Alternative Therapeutic Options to Antibiotics for the Treatment of Urinary Tract Infections.

Authors:  Paul Loubet; Jérémy Ranfaing; Aurélien Dinh; Catherine Dunyach-Remy; Louis Bernard; Franck Bruyère; Jean-Philippe Lavigne; Albert Sotto
Journal:  Front Microbiol       Date:  2020-07-03       Impact factor: 5.640

Review 3.  Potential of Therapeutic Bacteriophages in Nosocomial Infection Management.

Authors:  Nannan Wu; Tongyu Zhu
Journal:  Front Microbiol       Date:  2021-01-28       Impact factor: 5.640

Review 4.  A combination therapy of Phages and Antibiotics: Two is better than one.

Authors:  Xianghui Li; Yuhua He; Zhili Wang; Jiacun Wei; Tongxin Hu; Jiangzhe Si; Guangzhao Tao; Lei Zhang; Longxiang Xie; Abualgasim Elgaili Abdalla; Guoying Wang; Yanzhang Li; Tieshan Teng
Journal:  Int J Biol Sci       Date:  2021-08-18       Impact factor: 6.580

Review 5.  Phage therapeutics: from promises to practices and prospectives.

Authors:  Kanika Bhargava; Gopal Nath; Amit Bhargava; G K Aseri; Neelam Jain
Journal:  Appl Microbiol Biotechnol       Date:  2021-11-25       Impact factor: 4.813

6.  Case Report: Chronic Bacterial Prostatitis Treated With Phage Therapy After Multiple Failed Antibiotic Treatments.

Authors:  Apurva Virmani Johri; Pranav Johri; Naomi Hoyle; Levan Pipia; Lia Nadareishvili; Dea Nizharadze
Journal:  Front Pharmacol       Date:  2021-06-10       Impact factor: 5.810

Review 7.  Bacteriophages of Klebsiella spp., their diversity and potential therapeutic uses.

Authors:  Warren P Herridge; Preetha Shibu; Jessica O'Shea; Thomas C Brook; Lesley Hoyles
Journal:  J Med Microbiol       Date:  2020-01-24       Impact factor: 2.472

8.  Non-active antibiotic and bacteriophage synergism to successfully treat recurrent urinary tract infection caused by extensively drug-resistant Klebsiella pneumoniae.

Authors:  Juan Bao; Nannan Wu; Yigang Zeng; Liguang Chen; Linlin Li; Lan Yang; Yiyuan Zhang; Mingquan Guo; Lisha Li; Jie Li; Demeng Tan; Mengjun Cheng; Jingmin Gu; Jinghong Qin; Jiazheng Liu; Shiru Li; Guangqiang Pan; Xin Jin; Bangxin Yao; Xiaokui Guo; Tongyu Zhu; Shuai Le
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

9.  Phage-Antibiotic Synergy Is Driven by a Unique Combination of Antibacterial Mechanism of Action and Stoichiometry.

Authors:  Carmen Gu Liu; Sabrina I Green; Lorna Min; Justin R Clark; Keiko C Salazar; Austen L Terwilliger; Heidi B Kaplan; Barbara W Trautner; Robert F Ramig; Anthony W Maresso
Journal:  mBio       Date:  2020-08-04       Impact factor: 7.867

Review 10.  The Safety and Toxicity of Phage Therapy: A Review of Animal and Clinical Studies.

Authors:  Dan Liu; Jonas D Van Belleghem; Christiaan R de Vries; Elizabeth Burgener; Qingquan Chen; Robert Manasherob; Jenny R Aronson; Derek F Amanatullah; Pranita D Tamma; Gina A Suh
Journal:  Viruses       Date:  2021-06-29       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.